← Browse by Condition
Medical Condition
endometrial cancer
Total Trials
32
Recruiting Now
32
Trial Phases
Phase 1, Phase 3, Phase 2, Phase 3
NCT05787587 Phase 1
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
NCT04196257 Phase 1
Recruiting
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
Enrollment
50 pts
Location
United States
Sponsor
Bio-Path Holdings, Inc.
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Enrollment
110 pts
Location
United States, Austr...
Sponsor
Alterome Therapeutics, Inc.
NCT03785288 Phase 3
Recruiting
Vaginal Cuff Brachytherapy Fractionation Study
Enrollment
258 pts
Location
United States
Sponsor
Kara Romano, MD
NCT05349227
Recruiting
Comprehensive Outcomes for After Cancer Health
Enrollment
625 pts
Location
United States
Sponsor
Pack Health
NCT07148154
Recruiting
Development of a Non-invasive IVD for Endometrial Cancer Screening on High-risk Populations
Enrollment
3,000 pts
Location
Spain
Sponsor
MiMARK Diagnostics, S.L.
NCT05797831 Phase 2, Phase 3
Recruiting
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Enrollment
268 pts
Location
United States, Austr...
Sponsor
Kartos Therapeutics, Inc.
NCT06973161
Recruiting
ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Enrollment
105 pts
Location
United States, Austr...
Sponsor
AstraZeneca
NCT06395519 Phase 1, Phase 2
Recruiting
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
NCT05876130
Recruiting
Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer
Enrollment
92 pts
Location
South Korea
Sponsor
Samsung Medical Center
NCT04683653 Phase 1, Phase 2
Recruiting
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
Enrollment
100 pts
Location
United States
Sponsor
University of Chicago
NCT07220239
Recruiting
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
Enrollment
25 pts
Location
United States
Sponsor
Jessica D. St. Laurent, MD
NCT06409052
Recruiting
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women
Enrollment
45 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT07327489
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies
Enrollment
2,000 pts
Location
United States
Sponsor
Elephas
NCT04789694 Phase 3
Recruiting
Prehabilitation in Gynaecological Cancer Patients
Enrollment
64 pts
Location
Czechia
Sponsor
Charles University, Czech Repu...
NCT03787056
Recruiting
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
NCT07054567 Phase 2
Recruiting
A Study of BL-B01D1 + Pembrolizumab ± Bevacizumab in Patients With Recurrent or Metastatic Cervical Cancer and Endometrial Cancer
Enrollment
96 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
NCT06774209
Recruiting
Multimodal PET Imaging in the Diagnosis and Treatment of Pelvic Tumors
Enrollment
30 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT06846775
Recruiting
The Clinical Utility of DNA Methylation Testing in Patient-collected Urine and Vaginal Samples to Detect Endometrial Cancer: a Case-control Study
Enrollment
120 pts
Location
Denmark
Sponsor
University of Aarhus
NCT05610501
Recruiting
Ultrasound-guided Tru-Cut Biopsy in Pelvic Masses.
Enrollment
200 pts
Location
Belgium, Czechia, It...
Sponsor
Universitaire Ziekenhuizen KU ...
NCT05255653 Phase 2, Phase 3
Recruiting
Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features
Enrollment
1,615 pts
Location
Canada, France, Neth...
Sponsor
Leiden University Medical Cent...
NCT07200466
Recruiting
Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation
Enrollment
735 pts
Location
Netherlands
Sponsor
Radboud University Medical Cen...
NCT04512144
Recruiting
Mindfulness in Endometrial and Cervical Cancer
Enrollment
120 pts
Location
United States
Sponsor
St. Louis University
NCT07470853 Phase 1
Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Enrollment
265 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
NCT05914974
Recruiting
Immunotherapy-related CRP Kinetics in Metastatic Gynecological Malignancies
Enrollment
120 pts
Location
Germany
Sponsor
University Hospital Tuebingen
NCT06751589 EARLY_Phase 1
Recruiting
A Study of a Weight Loss Intervention in People With Endometrial Cancer
Enrollment
36 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
NCT06276491 Phase 1
Recruiting
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Enrollment
282 pts
Location
United States
Sponsor
Xencor, Inc.
NCT04585750 Phase 1, Phase 2
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc
NCT07278986 EARLY_Phase 1
Recruiting
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer
Enrollment
10 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn...
NCT07397624
Recruiting
Endoscopic Suture Gastroplasty (ESG) for Treatment of Obese Patients With Endometrial Cancer
Enrollment
74 pts
Location
Italy
Sponsor
Centro di Riferimento Oncologi...
NCT07435623
Recruiting
Late Radiation Toxicities in Cervical and Endometrial Cancer: A Postoperative IMRT/Brachytherapy Study
Enrollment
300 pts
Location
India
Sponsor
Tata Memorial Hospital
NCT07209449 Phase 2
Recruiting
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
Enrollment
75 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...